Inogen, Inc.
INGN
NASDAQ·Healthcare·Medical - Devices·Mkt cap $146.7M
$5.42
▼ -0.55%
P/E
-5.96
Mkt Cap
$146.7M
52-Wk Range
$5.29–$9.13
52-Week Range
$5.29 - $9.13
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 35.9% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
6 reasons
- Proprietary portable oxygen concentrator technology enabling greater patient mobility and independence
- Strong brand recognition and market leadership in portable oxygen therapy segment
- Diversified revenue streams including device sales, rentals, and accessories creating recurring revenue
- Direct-to-patient distribution channel reducing intermediaries and improving margins
- Established relationships with physicians, clinicians, and third-party payors
- International expansion opportunities in underpenetrated markets
Bear Case
1 risk
- Above-average volatility (beta 1.6).
Growth
Stable outlook
Positive revenue trend
Value
Deep value opportunity - significant discount to Medical Devices peers
Momentum
Weak
-10.6% over 3m
Quality
Strong
Solid business
Dividend
None
No dividend
Smart-money signal
Who's buying INGN right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 4, 2026
AUG 6, 2026
Reported EPS of -$0.14 vs -$0.15 consensus (+8.7% surprise). Revenue of $95.1M vs $95.2M expected (-0.2%).
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+8.7%
Revenue trend · last 8Q
—
+6%
+5%
+4%
+4%
+2%
+3%
+3%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$88.8M
$80.1M
$82.3M
$92.3M
$92.4M
$81.7M
$85.1M
$95.1M
Margins · last 8Q
Gross
41.4%
Operating
-6.3%
Profit
-4.0%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How INGN stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related